Mesenchymal stem cells regulate the proliferation of T cells via the growth-related oncogene/CXC chemokine receptor, CXCR2

Cellular Immunology

Volumn 279, Issue 1, 2012, Pages 1-11

  Lee, Yong Soo ^a   Won, Kyung Jong ^b   Park, Sung Won ^a   Lee, Hyeon Woo ^c   Kim, Bokyung ^b   Kim, Jin Hoi ^d   Kim, Dong Ku ^d  

^a CHA University   (South Korea)

^b Konkuk University School of Medicine   (South Korea)

^c Kyung Hee University   (South Korea)

^d Konkuk University   (South Korea)

Author keywords

CXCR2 receptor; GRO; Immunosuppression; Mesenchymal stem cells; T cells; Tumor animal model

Indexed keywords

CHEMOKINE RECEPTOR CXCR2; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; CXCL3 CHEMOKINE; CYTOKINE; JANUS KINASE 2; PROTEIN KINASE B; STAT3 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER TISSUE; CELL ASSAY; CELL DEATH; CELL ISOLATION; COCULTURE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; INHIBITION KINETICS; LYMPHOCYTE PROLIFERATION; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; T LYMPHOCYTE;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; CELL PROLIFERATION; CELLS, CULTURED; CHEMOKINE CXCL1; CHEMOKINE CXCL2; CHEMOKINES, CXC; CORD BLOOD STEM CELL TRANSPLANTATION; FLOW CYTOMETRY; HELA CELLS; HUMANS; JANUS KINASE 2; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED NOD; MICE, SCID; MICROSCOPY, FLUORESCENCE; PHOSPHORYLATION; RECEPTORS, INTERLEUKIN-8B; STAT3 TRANSCRIPTION FACTOR; T-LYMPHOCYTES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

ANIMALIA;

EID: 84871653500     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2012.08.002     Document Type: Article

References (40)

1. Almeida-Porada G., Flake A.W., Glimp H.A., Zanjani E.D. Cotransplantation of stroma results in enhancement of engraftment and early expression of donor hematopoietic stem cells in utero. Exp. Hematol. 1999, 27:1569-1575.
2. Angelopoulou M., Novelli E., Grove J.E., Rinder H.M., Civin C., Cheng L., Krause D.S. Cotransplantation of human mesenchymal stem cells enhances human myelopoiesis and megakaryocytopoiesis in NOD/SCID mice. Exp. Hematol. 2003, 31:413-420.
3. in 't Anker P.S., Noort W.A., Kruisselbrink A.B., Scherjon S.A., Beekhuizen W., Willemze R., Kanhai H.H., Fibbe W.E. Nonexpanded primary lung and bone marrow-derived mesenchymal cells promote the engraftment of umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Exp. Hematol. 2003, 31:881-889.
4. Liu Z.J., Zhuge Y., Velazquez O.C. Trafficking and differentiation of mesenchymal stem cells. J. Cell. Biochem. 2009, 106:984-991.
5. Maitra B., Szekely E., Gjini K., Laughlin M.J., Dennis J., Haynesworth S.E., Koc O.N. Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Bone Marrow Transplant. 2004, 33:597-604.
6. Uccelli A., Pistoia V., Moretta L. Mesenchymal stem cells: a new strategy for immunosuppression?. Trends Immunol. 2007, 28:219-226.
7. Aggarwal S., Pittenger M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005, 105:1815-1822.
8. Maccario R., Podesta M., Moretta A., Cometa A., Comoli P., Montagna D., Daudt L., Ibatici A., Piaggio G., Pozzi S., Frassoni F., Locatelli F. Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype. Haematologica 2005, 90:516-525.
9. Rasmusson I., Ringden O., Sundberg B., Le Blanc K. Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation 2003, 76:1208-1213.
10. Klyushnenkova E., Mosca J.D., Zernetkina V., Majumdar M.K., Beggs K.J., Simonetti D.W., Deans R.J., McIntosh K.R. T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression. J. Biomed. Sci. 2005, 12:47-57.
11. Liu J., Lu X.F., Wan L., Li Y.P., Li S.F., Zeng L.Y., Zeng Y.Z., Cheng L.H., Lu Y.R., Cheng J.Q. Suppression of human peripheral blood lymphocyte proliferation by immortalized mesenchymal stem cells derived from bone marrow of Banna Minipig inbred-line. Transplant. Proc. 2004, 36:3272-3275.
12. Meisel R., Zibert A., Laryea M., Gobel U., Daubener W., Dilloo D. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 2004, 103:4619-4621.
13. Corcione A., Benvenuto F., Ferretti E., Giunti D., Cappiello V., Cazzanti F., Risso M., Gualandi F., Mancardi G.L., Pistoia V., Uccelli A. Human mesenchymal stem cells modulate B-cell functions. Blood 2006, 107:367-372.
14. Jiang X.X., Zhang Y., Liu B., Zhang S.X., Wu Y., Yu X.D., Mao N. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 2005, 105:4120-4126.
15. Ebnet K., Vestweber D. Molecular mechanisms that control leukocyte extravasation: the selectins and the chemokines. Histochem. Cell Biol. 1999, 112:1-23.
16. Luan J., Shattuck-Brandt R., Haghnegahdar H., Owen J.D., Strieter R., Burdick M., Nirodi C., Beauchamp D., Johnson K.N., Richmond A. Mechanism and biological significance of constitutive expression of MGSA/GRO chemokines in malignant melanoma tumor progression. J. Leukoc. Biol. 1997, 62:588-597.
17. Smith D.R., Polverini P.J., Kunkel S.L., Orringer M.B., Whyte R.I., Burdick M.D., Wilke C.A., Strieter R.M. Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma. J. Exp. Med. 1994, 179:1409-1415.
18. Wang B., Hendricks D.T., Wamunyokoli F., Parker M.I. A growth-related oncogene/CXC chemokine receptor 2 autocrine loop contributes to cellular proliferation in esophageal cancer. Cancer Res. 2006, 66:3071-3077.
19. Vandercappellen J., Van Damme J., Struyf S. The role of CXC chemokines and their receptors in cancer. Cancer Lett. 2008, 267:226-244.
20. Acosta J.C., O'Loghlen A., Banito A., Guijarro M.V., Augert A., Raguz S., Fumagalli M., Da Costa M., Brown C., Popov N., Takatsu Y., Melamed J., d'Adda di Fagagna F., Bernard D., Hernando E., Gil J. Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell 2008, 133:1006-1018.
21. Shyamala V., Khoja H. Interleukin-8 receptors R1 and R2 activate mitogen-activated protein kinases and induce c-fos, independent of Ras and Raf-1 in Chinese hamster ovary cells. Biochemistry 1998, 37:15918-15924.
22. Dhawan P., Richmond A. Role of CXCL1 in tumorigenesis of melanoma. J. Leukoc. Biol. 2002, 72:9-18.
23. Pelus L.M., Fukuda S. Peripheral blood stem cell mobilization: the CXCR2 ligand GRObeta rapidly mobilizes hematopoietic stem cells with enhanced engraftment properties. Exp. Hematol. 2006, 34:1010-1020.
24. Smith D.F., Galkina E., Ley K., Huo Y. GRO family chemokines are specialized for monocyte arrest from flow. Am. J. Physiol. Heart Circ. Physiol. 2005, 289:H1976-H1984.
25. Catusse J., Liotard A., Loillier B., Pruneau D., Paquet J.L. Characterization of the molecular interactions of interleukin-8 (CXCL8), growth related oncogen alpha (CXCL1) and a non-peptide antagonist (SB 225002) with the human CXCR2. Biochem. Pharmacol. 2003, 65:813-1821.
26. Chamberlain G., Wright K., Rot A., Ashton B., Middleton J. Murine mesenchymal stem cells exhibit a restricted repertoire of functional chemokine receptors: comparison with human. PLoS One 2008, 3:e2934.
27. Croitoru-Lamoury J., Lamoury F.M., Zaunders J.J., Veas L.A., Brew B.J. Human mesenchymal stem cells constitutively express chemokines and chemokine receptors that can be upregulated by cytokines, IFN-beta, and Copaxone. J. Interferon Cytokine Res. 2007, 27:53-64.
28. Ponte A.L., Marais E., Gallay N., Langonne A., Delorme B., Herault O., Charbord P., Domenech J. The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells 2007, 25:1737-1745.
29. Ringe J., Strassburg S., Neumann K., Endres M., Notter M., Burmester G.R., Kaps C., Sittinger M. Towards in situ tissue repair: human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2 and CCR2, and migrate upon stimulation with CXCL8 but not CCL2. J. Cell. Biochem. 2007, 101:135-146.
30. Rasmusson I., Ringden O., Sundberg B., Le Blanc K. Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms. Exp. Cell Res. 2005, 305:33-41.
31. Plumas J., Chaperot L., Richard M.J., Molens J.P., Bensa J.C., Favrot M.C. Mesenchymal stem cells induce apoptosis of activated T cells. Leukemia 2005, 19:1597-1604.
32. White J.R., Lee J.M., Young P.R., Hertzberg R.P., Jurewicz A.J., Chaikin M.A., Widdowson K., Foley J.J., Martin L.D., Griswold D.E., Sarau H.M. Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration. J. Biol. Chem. 1998, 273:10095-10098.
33. Glennie S., Soeiro I., Dyson P.J., Lam E.W., Dazzi F. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 2005, 105:2821-2827.
34. Hassan J., Reen D.J. Cord blood CD4+ CD45RA+ T cells achieve a lower magnitude of activation when compare with their adult counterparts. Immunology 1997, 90:397-401.
35. Beyth S., Borovsky Z., Mevorach D., Liebergall M., Gazit Z., Aslan H., Galun E., Rachmilewitz J. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 2005, 105:2214-2219.
36. Spaggiari G.M., Capobianco A., Becchetti S., Mingari M.C., Moretta L. Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood 2006, 107:1484-1490.
37. Brennan P., Babbage J.W., Burgering B.M., Groner B., Reif K., Cantrell D.A. Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F. Immunity 1997, 7:679-689.
38. Matikainen S., Sareneva T., Ronni T., Lehtonen A., Koskinen P.J., Julkunen I. Interferon-alpha activates multiple STAT proteins and upregulates proliferation-associated IL-2Ralpha, c-myc, and pim-1 genes in human T cells. Blood 1999, 93:1980-1991.
39. Nel A.E. T-cell activation through the antigen receptor. Part 1: signaling components, signaling pathways, and signal integration at the T-cell antigen receptor synapse. J Allergy. Clin. Immunol. 2002, 109:758-770.
40. Yu W.M., Wang S., Keegan A.D., Williams M.S., Qu C.K. Abnormal Th1 cell differentiation and IFN-gamma production in T lymphocytes from motheaten viable mice mutant for Src homology 2 domain-containing protein tyrosine phosphatase-1. J. Immunol. 2005, 174:1013-1019.